Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - CAPITAL EXPENDITURES
Capital Expenditures APLS - Apellis Pharmaceuticals, Inc.
-773 K
LAST VALUE
16.29%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR